Old CIC Events

Defensa de la tesis doctoral: Functional Analysis of PCNA Deubiquitylation in Replication Fork Dynamics and Okazaki Fragment Maturation in Saccharomyces cerevisiae
Javier Zamarreño Lozano — Programa de doctorado de biociencias: biología y clínica de cáncer

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies
Xosé S. Puente — IUOPA-Universidad de Oviedo

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.
Cristian Prieto — IBCII - Univ. Frankfurt

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression
Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies
Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

The long journey to develop a drug against an “undruggable” target in cancer
Laura Soucek — Vall d´Hebron, Barcelona

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer
Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability
Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

Metabolic Control of Cell Fate in Regeneration and Cancer
Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer
Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer

Dissecting metastatic Bladder Cancer
Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer
Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London